Navigation Links
LifeCell Corporation Revises Full Year 2007 Preliminary Results and Schedules Fourth Quarter 2007 Financial Results Conference Call; February 27, 2008 at 10:00 a.m. Eastern
Date:2/7/2008

BRANCHBURG, N.J., Feb. 7 /PRNewswire-FirstCall/ -- LifeCell Corporation (Nasdaq: LIFC), today announced revised preliminary full-year 2007 diluted net income per share due to the final settlement of a claim that arose in 2007. The claim, which was not product related, is expected to reduce diluted net income per share by approximately $0.03. "Although the final resolution of the claim occurred in 2008, since the Company's 2007 financial statements were not yet filed with the Securities and Exchange Commission, we are required to report the amount as a fourth quarter 2007 item," stated Steven Sobieski, LifeCell's Chief Financial Officer. The Company now anticipates full-year 2007 diluted net income per share to be in the range $0.77 to $0.78 compared to the previously announced range of $0.80 to $0.82. The change in estimate is entirely related to the settlement.

The Company also announced that it plans to release fourth quarter and full year 2007 actual operating results on Wednesday, February 27, 2008 at 8:00 a.m. Eastern. Paul Thomas, President and Chief Executive Officer, will host a conference call at 10:00 a.m. Eastern, to discuss the Company's fourth quarter and full year 2007 financial results.

The dial-in number for the call is (877) 419-6590/domestic or (719) 325- 4855/international. A simultaneous webcast of the call will be available via LifeCell's website at http://www.lifecell.com Corporate Information - Investor Relations. The call will be archived on the Company's website for at least 90 days.

A recording of the live-call will be available through March 6, 2008. The dial-in number to listen to the recording is (888) 203-1112 or (719) 457-0820. The repl
'/>"/>

SOURCE LifeCell Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. LifeCell Corporation Schedules Third Quarter 2007 Financial Results Conference Call; October 25, 2007 at 10:00 A.M. Eastern
2. LifeCell Corporation Schedules 2008 Financial Guidance Release and Conference Call; January 7, 2008 at 10:00 A.M. Eastern
3. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
4. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
5. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
6. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
7. BioElectronics Corporation Announces Singapore and Malaysia Sales
8. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
9. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
10. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
11. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... -- Ambit Biosciences Corporation announced today the enrollment and ... Cancer Center of the first patient in the ACE ... fficacy) Phase 2 pivotal trial in patients with ... is a novel, orally available, potent and highly selective ... tyrosine kinase-3 (FLT3) inhibitor. The ACE study is ...
(Date:12/11/2009)... 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ... the appointment of Dr. Alan Warrander to the ... Business Development. ,, "Dr. Warrander will be responsible ... for REOLYSIN(R)," said Dr. Brad Thompson, President and ... the design of a Phase 3 trial examining ...
(Date:12/10/2009)... Endologix, Inc. (Nasdaq: ELGX ), ... announced today that Dan Lemaitre, former President and ... of Directors effective December 11, 2009. Endologix ... directors. ,, Franklin D. Brown, Chairman of the ... Lemaitre to the Endologix Board of Directors. ...
(Date:12/10/2009)... Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... sciences product development company that identifies and advances ... various stages of development, today provided an update ... the merger of Cytopia Ltd. into YM, details ... The board of directors of Cytopia has unanimously ...
Breaking Biology Technology:Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Endologix Appoints Dan Lemaitre to its Board of Directors 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4
... Covance Inc. (NYSE:,CVD) today announced that it will ... Device Conference on February 6th,at 9:20 am ET. Investors ... http://www.covance.com . In order to register and download any ... with headquarters in Princeton, New Jersey, is one of ...
... Bulletin Board: NILT), announced today that Peter M. Strumph,Chief ... Investor Conference,at the Waldorf-Astoria Hotel in New York City ... Strumph will provide an overview of Nile and an,update ... be webcast live and can be accessed by visiting,the ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:,ONTY) (TSX: ONY), a ... products for the treatment of cancer, today,announced the ... http://www.oncothyreon.com ., "We are excited about our ... website, which provides additional information about our,product pipeline ...
Other Biology Technology:Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference 2
(Date:12/14/2009)... December 10, 2009If you are spending the holidays with ... whether you would be better off with another family, ... , A research team from McMaster University and the ... cichlids, a species that lives in groups, members make ... results appear in the current issue of Biology ...
(Date:12/14/2009)... As good as laparoscopy is in preventing some of the ... drawbacks, including reduced blood flow and organ dysfunction. Laparoscopy is ... incisions. , By adding another gas ... during laparoscopy, researchers at Duke University Medical Center have found ... , The gas ethyl nitrite (ENO) helped to open ...
(Date:12/13/2009)... CADecember 10, 2009Researchers at The Scripps Research Institute ... single protein from an ancient family of enzymes ... body. In addition to providing guidance for understanding ... a theoretical underpinning for the protein,s possible use ... , The research was published in the December ...
Breaking Biology News(10 mins):Gas improves blood flow and organ status during minimally invasive surgery 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3DJ AM 3A Why He Went Too Far Phoenix House Thought Piece for National Recovery Month by Dr Deni Carise 56569 1DJ AM 3A Why He Went Too Far Phoenix House Thought Piece for National Recovery Month by Dr Deni Carise 56569 2DJ AM 3A Why He Went Too Far Phoenix House Thought Piece for National Recovery Month by Dr Deni Carise 56569 3DJ AM 3A Why He Went Too Far Phoenix House Thought Piece for National Recovery Month by Dr Deni Carise 56569 4Doctors Stand Together Against Government Takeover of Healthcare on Sept 10th in DC 56566 1Thomson Joins Brooks Kushman 3B Strengthens Los Angeles Presence 13942 1Thomson Joins Brooks Kushman 3B Strengthens Los Angeles Presence 13942 2
... Clinic-led research collaboration has discovered that the protein MDC1 ... begin. Once amplified, even low-level damage signals become strong ... the injury is most tractable to repair. , ... this finding, which appears in the January 20 issue ...
... of the humpback whale are among the most complex in ... have their own syntax that uses sound units to build ... for hours. , Until now, only humans have demonstrated the ... research, published online in the March 2006 issue of the ...
... at the University at Buffalo and the University ... two intracellular events, both stimulated by the same ... , The broad implication of the findings may ... underpinnings of mammalian behavior, according to the researchers. ...
Other Biology News:Mayo Clinic collaboration discovers protein amplifies DNA injury signals 2Mayo Clinic collaboration discovers protein amplifies DNA injury signals 3Warbling whales speak a language all their own 2Warbling whales speak a language all their own 3Manipulating single cell receptor alters animal behavior 2Manipulating single cell receptor alters animal behavior 3
Amino-acids and Derivatives Rabbit Anti-conjugated L-isoleucine Polyclonal Antibody...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Mouse monoclonal [88B] to nicotinic Acetylcholine Receptor ( Abpromise for all tested applications)....
D4-GDI rabbit polyclonal antibody...
Biology Products: